{"doi":"10.1016/j.febslet.2009.10.012","title":"Membrane microdomains and insulin resistance","abstract":"<jats:p>A new concept, that “metabolic disorders, such as type 2 diabetes, are membrane microdomain disorders caused by aberrant expression of gangliosides”, has arisen. By examining this working hypothesis, we demonstrate the molecular pathogenesis of type 2 diabetes and insulin resistance focusing on the interaction between insulin receptor and gangliosides in microdomains and propose the new therapeutic strategy “membrane microdomain ortho‐signaling therapy”.</jats:p>","journal":"FEBS Letters","year":2010,"id":633106,"datarank":0.6261580904843456,"base_score":4.174387269895637,"endowment":4.174387269895637,"self_citation_contribution":0.6261580904843456,"citation_network_contribution":0.0,"self_endowment_contribution":0.6261580904843456,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":64,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1641280,"name":"Jin-ichi Inokuchi","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Membrane microdomains and insulin resistance","abstract":"<jats:p>A new concept, that “metabolic disorders, such as type 2 diabetes, are membrane microdomain disorders caused by aberrant expression of gangliosides”, has arisen. By examining this working hypothesis, we demonstrate the molecular pathogenesis of type 2 diabetes and insulin resistance focusing on the interaction between insulin receptor and gangliosides in microdomains and propose the new therapeutic strategy “membrane microdomain ortho‐signaling therapy”.</jats:p>","is_dataset_classified":null,"base_score":4.174387269895637,"endowment":4.174387269895637,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19822143","pmcid":null,"openalex_id":"https://openalex.org/W2064434693","authors":[],"funders":[{"funder_name":"Ministry of Education, Culture, Sports, Science and Technology","grant_id":"","title":null},{"funder_name":"Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency","grant_id":"","title":null}],"total_grants":2,"fwci":1.7766,"citation_percentile":0.82992248,"influential_citations":0,"citation_trend":[{"year":2012,"count":6},{"year":2013,"count":8},{"year":2014,"count":7},{"year":2015,"count":9},{"year":2016,"count":4},{"year":2017,"count":4},{"year":2018,"count":5},{"year":2019,"count":2},{"year":2020,"count":3},{"year":2021,"count":2},{"year":2022,"count":5},{"year":2024,"count":1}],"oa_status":"bronze","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2009.10.012","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2009.10.012","host_type":"publisher"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.febslet.2009.10.012","host_type":"publisher"},{"url":"https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/j.febslet.2009.10.012","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.febslet.2009.10.012","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/19822143","host_type":"repository"}],"fields_of_study":["Caveolin-1 and cellular processes","Glycosylation and Glycoproteins Research","Galectins and Cancer Biology","Animals","Biomarkers","G(M3) Ganglioside","Humans","Insulin Resistance","Membrane Microdomains","Metabolic Diseases","Models, Biological"],"mesh_terms":["Animals","G(M3) Ganglioside","Humans","Insulin Resistance","Metabolic Diseases","Models, Biological","Biomarkers","Membrane Microdomains"],"keywords":["Lipid microdomain","Insulin resistance","Insulin receptor","Type 2 diabetes","Pathogenesis","Membrane","Receptor","Insulin","Cell biology","Diabetes mellitus","Endocrinology","Biology","Internal medicine","Biochemistry","Medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T11:00:03.911238Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}